StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Strong revenue growth and profit turnaround signal positive company performance despite stock drop. Similar past performance improvements have led to recovery in stock prices.
What happened, with direct paths to the underlying reporting
OGI's Q2 2025 net sales rose 74% year-over-year, totaling CA$65.6 million. Gross revenue increased 79% driven by Motif acquisition and international sales. Adjusted gross margin improved to 33%, expected to rise further as synergies are realized. Organigram reported a net income of CA$42.5 million, reversing last year's loss. Stock price dropped 11% to $1.54 during premarket trading after earnings release.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.